1. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi Kim, Maria H.; Tembo, Tapiwa A.; Mazenga, Alick; Yu, Xiaoying; Myer, Landon; Sabelli, Rachael; Flick, Robert; Hartig, Miriam; Wetzel, Elizabeth; Simon, Katie; Ahmed, Saeed; Nyirenda, Rose; Kazembe, Peter N.; Mphande, Mtisunge; Mkandawire, Angella; Chitani, Mike J.; Markham, Christine; Ciaranello, Andrea; Abrams, Elaine J. 2020 Articles HIV (Viruses)Highly active antiretroviral therapyVirus diseases--TransmissionMothers--Health and hygiene
2. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis Dunning, Lorna; Francke, Jordan A.; Mallampati, Divya; MacLean, Rachel L.; Penazzato, Martina; Hou, Taige; Myer, Landon; Abrams, Elaine J.; Walensky, Rochelle P.; Leroy, Valeriane; Freedberg, Kenneth A.; Ciaranello, Andrea 2017 Articles HIV infections--DiagnosisNewborn infants--Diseases--DiagnosisMedical care--Cost effectivenessEpidemiology
3. The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial Mogoba, Phepo; Lesosky, Maia; Zerbe, Allison; Falcao, Joana; Mellins, Claude A.; Desmond, Christopher; Arnaldo, Carlos; Kapogiannis, Bill; Myer, Landon; Abrams, Elaine J. 2021 Articles Clinical trialsHighly active antiretroviral therapyHIV infectionsTeenagers--Medical care
4. Task sharing of a psychological intervention for maternal depression in Khayelitsha, South Africa: study protocol for a randomized controlled trial Lund, Crick; Schneider, Marguerite; Davies, Thandi; Nyatsanza, Memory; Honikman, Simone; Bhana, Arvin; Bass, Judith; Bolton, Paul; Dewey, Michael; Joska, John; Kagee, Ashraf; Myer, Landon; Petersen, Inge; Prince, Martin; Stein, Dan; Thornicroft, Graham; Tomlinson, Mark; Alem, Atalay; Susser, Ezra S. 2014 Articles Public healthPsychology
5. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study Abrams, Elaine J.; Bekker, Linda-Gail; Myer, Landon; Zulliger, Rose 2012 Articles Public health
6. Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective Study Phillips, Tamsin; Cois, Annibale; Remien, Robert Howard; Mellins, Claude A.; McIntyre, James A.; Petro, Greg; Abrams, Elaine J.; Myer, Landon 2016 Articles PregnancyHIV infections--TreatmentHIV-positive personsImmunology
7. Re-recruiting postpartum women living with HIV into a follow-up study in Cape Town, South Africa Mogoba, Phepo; Gomba, Yolanda; Brittain, Kirsty; Phillips, Tamsin K.; Zerbe, Allison; Myer, Landon; Abrams, Elaine J. 2019 Articles PuerperiumHIV-positive womenHealth surveysRecruiting and enlistmentHIV-positive children
8. Pregnant and breastfeeding women: A priority population for HIV viral load monitoring Myer, Landon; Essajee, Shaffiq; Broyles, Laura N.; Watts, D. Heather; Lesosky, Maia; El-Sadr, Wafaa Mahmoud; Abrams, Elaine J. 2017 Articles HIV infectionsPregnancyBreastfeedingMedicineAntiretroviral agents
9. Policy maker and health care provider perspectives on reproductive decision-making amongst HIV-infected individuals in South Africa Harries, Jane; Cooper, Diane; Myer, Landon; Bracken, Hillary; Zweigenthal, Virginia; Orner, Phyllis 2007 Articles Medical policyPublic health administrationReproductive health--Decision makingHIV-positive personsPublic healthHealth services administrationMedical care
10. Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa Lawn, Stephen; Myer, Landon; Bangani, Nonzwakazi; Vogt, Monica; Wood, Robin 2007 Articles HIV infections--EpidemiologyAntiretroviral agentsHIV infections--ComplicationsPlasminogen activatorsEpidemiology